3min chapter

The HemOnc Pulse cover image

Amer Zeidan, MBBS, MHS, on the Evolution of AML Classification, Treatment

The HemOnc Pulse

CHAPTER

The Future of Morphology in APL and CML

I can't recall a prospective randomized control trial in APL or CML where people who had elevation in the transcript that you are detecting were randomized to observation versus preemptive therapy. I believe the field just thought we should do that. The issue is that without clear data on a randomized setting, it's going to be always challenged as an experience of opinion. Dr. Amers-Edan, thank you so much for spending some time with me on the Heman pulse.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode